<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="123344">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01496846</url>
  </required_header>
  <id_info>
    <org_study_id>PG#N014189</org_study_id>
    <secondary_id>HUM00049692</secondary_id>
    <secondary_id>HUM00088384</secondary_id>
    <nct_id>NCT01496846</nct_id>
  </id_info>
  <brief_title>Efficacy Study of Articaine Versus Lidocaine as Supplemental Infiltration in Inflamed Molars</brief_title>
  <acronym>ARTIC</acronym>
  <official_title>Articaine Versus Lidocaine Supplemental Infiltration Efficacy in Irreversible Pulpitis Mandibular Molars After Failed Inferior Alveolar Nerve Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dentsply International</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to study the ability of a frequently used dental anesthetic
      (articaine) to achieve complete numbness of a diseased tooth with the most commonly used
      injection technique in the lower jaw (inferior alveolar nerve block: IANB). If this
      technique fails, a commonly used supplemental technique with one of two possible dental
      anesthetics (lidocaine or articaine) will be given to evaluate the success/failure of
      complete numbness between the two anesthetics.

      The investigators hypothesize that supplemental infiltration anesthesia with articaine will
      give the same success rate as lidocaine in achieving complete pulpal anesthesia in
      mandibular molars with irreversible pulpits.

      This study consisted of two periods of patient enrollment, treatment and data collection:
      Part I: 101 subjects; Part II: 100 subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of the study is to achieve complete pulpal anesthesia in irreversible pulpitis
      mandibular molars, either by IANB administration of 4% articaine with 1:100,000 epinephrine
      (NDA 022466), or in case the IANB appeared to be clinically unsuccessful by supplemental
      infiltration of either articaine or lidocaine.

      The proposed randomized controlled trial (RCT) aims to answer the following questions:

        1. What is the success rate of an IANB with articaine using a conventional IANB technique
           and standardized speed of administration?

        2. Is there a difference in complete pulpal anesthetic efficacy using supplemental
           infiltration with either articaine or lidocaine after an unsuccessful articaine IANB?

        3. Is there a difference in first or second molars in achieving complete pulpal anesthesia
           using supplemental infiltration with either articaine or lidocaine?

      This study will combine the data from HUM00049692- Articaine Efficacy in Inflamed Molars to
      create a larger sample size, giving a total sample size of approximately 200 patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anesthetic success rate of supplemental infiltration injection</measure>
    <time_frame>5 min after injection</time_frame>
    <description>Following an unsuccessful IANB, supplemental infiltration anesthesia with either articaine or lidocaine will be given to achieve complete pulpal anesthesia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anesthetic success rate of an IANB with articaine</measure>
    <time_frame>15 min after injection</time_frame>
    <description>Success rate of an IANB with articaine using a conventional IANB technique</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">201</enrollment>
  <condition>Irreversible Pulpitis</condition>
  <arm_group>
    <arm_group_label>Articaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Supplemental buccal anesthesia with articaine local anesthetic after unsuccessful IANB.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Supplemental buccal anesthesia with lidocaine local anesthetic after unsuccessful IANB.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Articaine local anesthetic</intervention_name>
    <description>After unsuccessful IANB, proceed to give 1.7cc of either 4% articaine with 1:100,000 epinephrine in buccal mucosa as a supplemental infiltration injection</description>
    <arm_group_label>Articaine</arm_group_label>
    <other_name>Articadent (Dentsply Pharmaceutical)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine local anesthetic</intervention_name>
    <description>After unsuccessful IANB, proceed to give 1.7cc 2% lidocaine with 1:100,000 epinephrine in buccal mucosa as a supplemental infiltration injection</description>
    <arm_group_label>Lidocaine</arm_group_label>
    <other_name>Generic lidocaine (Henry Schein Inc)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients

          -  irreversible pulpitis in mandibular molar

        Exclusion Criteria:

          -  below 18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mathilde C Peters, DMD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan, School of Dentistry Clinics</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Brandt RG, Anderson PF, McDonald NJ, Sohn W, Peters MC. The pulpal anesthetic efficacy of articaine versus lidocaine in dentistry: a meta-analysis. J Am Dent Assoc. 2011 May;142(5):493-504.</citation>
    <PMID>21531931</PMID>
  </reference>
  <results_reference>
    <citation>Rogers BS, McDonald NJ, Gardner R, Botero T, Shlafer M, Peters MC. Anesthetic Efficacy of Articaine vs Lidocaine as Supplemental Infiltration after Unsuccessful IANB of Irreversible Pulpitis Mandibular Molars. AAE Annual Meeting. Honolulu, Hawaii, April 2013.</citation>
  </results_reference>
  <results_reference>
    <citation>Rogers BS, Botero TM, McDonald NJ, Gardner RJ, Peters MC. Efficacy of articaine versus lidocaine as a supplemental buccal infiltration in mandibular molars with irreversible pulpitis: a prospective, randomized, double-blind study. J Endod. 2014 Jun;40(6):753-8. doi: 10.1016/j.joen.2013.12.022. Epub 2014 Feb 8.</citation>
    <PMID>24862701</PMID>
  </results_reference>
  <verification_date>March 2016</verification_date>
  <lastchanged_date>March 30, 2016</lastchanged_date>
  <firstreceived_date>December 9, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Mathilde Peters, DMD, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Articaine</keyword>
  <keyword>Lidocaine</keyword>
  <keyword>Anesthesia, Local</keyword>
  <keyword>Endodontics</keyword>
  <keyword>Molar</keyword>
  <keyword>Dental Pulp Diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pulpitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Carticaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
